Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$1.10
EPS est.
$0.43
EPS surprise
+154.04%
1-day move
-11.86%
Oscar Health reported a strong EPS that significantly exceeded expectations, indicating better-than-anticipated profitability. However, the stock fell by nearly 12%, suggesting investor concerns about other aspects of the business, possibly related to revenue performance or future outlook. Without guidance or management commentary, uncertainty remains about the company's direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.10 | $-0.23 | +154.04% |
| Revenue | — | $4.7B | — |
No transcript is on record, and the analysis is based on numerical results only.
Oscar Health, Inc. is a health insurance company focused on providing affordable and accessible healthcare solutions. Operating in the financial sector, it aims to leverage technology to improve customer experiences and streamline healthcare services, which is increasingly important as healthcare costs continue to rise.
Last quarter
In Q1 2026, Oscar reported an EPS of $2.07, significantly exceeding expectations of $1.21, which led to a positive market reaction. However, revenue details were not disclosed, leaving some uncertainty about overall performance.
Management promises and guidance
EPS beat streak
2Q
EPS beat rate
50%
Avg EPS surprise
-23.16%
Avg 1-day reaction
+1.33%
Analysts expect a challenging quarter with a consensus EPS of $-0.23, indicating ongoing struggles with profitability. Revenue expectations are set at $4.7B, reflecting cautious optimism about growth.
Bull case
If Oscar can beat EPS expectations and show strong revenue growth, it could signal a turnaround in profitability and market confidence, potentially leading to a significant stock price increase.
Bear case
Conversely, if the company misses on both EPS and revenue, it could raise concerns about its long-term viability, leading to a negative reaction in the stock price.
Key metrics to watch
EPS
$-0.23Earnings per share is a key indicator of profitability and will show how well Oscar is managing its costs and revenue.
Revenue
$4.7BTotal revenue will provide insight into the company's growth and market demand for its insurance products.
The print will turn on these.
Q1
Will EPS come in better than the consensus estimate of $-0.23?
A positive EPS surprise could indicate improved profitability and boost investor confidence.
Q2
What is the expected revenue growth compared to the consensus of $4.7B?
Revenue performance will be critical in assessing the company's market demand and overall health.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.1%
Why consensus could be wrong
The Street may be underestimating Oscar's ability to leverage technology for cost savings and customer acquisition, which could lead to better-than-expected results.
Supporting evidence
Recent performance showed a strong EPS surprise in Q1 2026, indicating potential for continued improvement.
The options market suggests a higher volatility expectation, indicating that investors are preparing for significant movements.
Management's focus on technology integration may yield unexpected efficiencies not yet reflected in consensus estimates.
Key risk
If Oscar's revenue exceeds $4.9B, it could challenge the current bearish sentiment and shift market perception.
Pre-commit to what would confirm each case.
This quarter's performance is crucial as it will determine whether Oscar can maintain momentum or if it will face further setbacks.
Bull confirmed if
An EPS of $0.05 or better would confirm a strong recovery and positive market sentiment.
Bear confirmed if
An EPS worse than $-0.31 would validate concerns about ongoing financial struggles.
What the market is pricing for the move.
Implied Move
±14.89%
Historical Avg
±10.2%
The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings announcement.
Options are pricing ±14.9% while OSCR has averaged ±10.2% over the last 8 prints — setup is pricing rich.
ATM IV
0.8%
30d HV
58.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Oscar beats expectations, history suggests a potential stock increase of around +8.74%, confirming a positive turnaround.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in management's future guidance.
Miss
A miss could lead to a decline of about -3.89%, indicating ongoing challenges and investor disappointment.
The lines on the call that would change the story.